Copptech: A Antiviral Biotech
The project's goal is to provide Covid-19 crisis response financing for sustaining andpromoting Copptech's expansion to improve households and business resilience against Covid-19. Copptech develops and manufactures chemicals based on zinc and copper that neutralize the effect of the Cov-SARS-2 virus in different types of surfaces, such as wood polymers and metals. Its requesting a loan from LIFESS to comply with a drastic increase in demand for its products.

Project Detail

Country

Chile

Project Number

CH-Q0007

Approval Date

January 10, 2023

Project Status

Implementation

Project Type

Equity

Sector

PRIVATE FIRMS AND SME DEVELOPMENT

Subsector

ENTERPRISE DEVELOPMENT, CLUSTERS AND INNOVATION

Lending Instrument

Multilateral Investment Fund Instrument

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental and Social Impact Category (ESIC)

-

Total Cost

USD 1.00

Country Counterpart Financing

USD 0.00

Original Amount Approved

USD 1.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
EQU/MS-19858-CH Non-Sovereign Guaranteed USD - United States Dollar MIF-Small Enterprise Investment Fund Equity Financing
Operation Number EQU/MS-19858-CH
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: MIF-Small Enterprise Investment Fund
  • Financial Instrument: Equity Financing